UT Health San Antonio leads effort for developing oral vaccine against chlamydia
The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in ...
Tag: Chlamydia
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. Food and Drug Administration (FDA) clearance for the NeuMoDx ...
A novel multi-epitope vaccine targeting extracellular proteins of Chlamydia pneumoniae
In a recent study published in Scientific Reports, a group of researchers designed and evaluated a multi-epitope vaccine targeting the ...
Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence
The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with ...
How feasible and accurate are self-collected samples for the diagnosis of monkeypox?
In a recent study posted to the medRxiv* server, a team of researchers evaluated the performance of monkeypox virus (MPXV)-infected ...
Duke researchers identify chlamydia’s stealthy cloaking device
Chlamydia, the leading cause of sexually transmitted bacterial infections, evades detection and elimination inside human cells by use of a ...
